I have had the pleasure and privilege of meeting Lindy twice over the last 2 months at both Oxford and our own AGM. She is one of the most incredible grounded decent human beings I have ever met. I am now invested in her and RG because I believe in them. Despite probably being a little out of their comfort zone, they have made incredible efforts and great strides to become commercial animals and maximise the shareholder value for you and me as well the larger shareholders. Once you get outside investment and are a quoted share the rules do change, To say I am not moral I find very offensive when you know nothing about and not understand any personal tragedy why I am involved in this share. No one is saying cancer drugs should become a cowboy market, of course not. But there must be a way of getting the right stuff to the market quicker, If you watched the cancer show on Wednesday on channel 4, these new treatments seemed archaic. The quicker Immunobody and moditope get to market and everything we believe on here is true and with extended life and lack of toxicity, that must be a good thing.
This is a commercial activity with ethics ... if you wish to sell Mumbo Jumbo Drugs to generate income through greed your in the wrong share, this is exactly why we have trials in the first place ..
RE: Wasted lives
If you read the detail of the Bill it seems it's not actually making any changes to what treatments a doctor can prescribe but simply how doctors are treated by the law when they "innovate" ie. move away from standard treatments. In other words they are already allowed to innovate but Saatchi argues that many don't for fear of being sued. The following articles demonstrate the flip side of the coin. http://www.stopthesaatchibill.co.uk/responsible-medical-innovation/ http://www.lexology.com/library/detail.aspx?g=137f2068-ad76-4625-9cce-ac9a87170870
This is a commercial business. Anything that can bring forward income in evaluating what we have within the patent period is a good thing for us and only increases the price.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.